Document is current
Any future updates will be listed below
-
Authors
Cancian, Giuseppe https://orcid.org/0000-0002-9497-3166
Paris, Arianna
Agliati, Lia
Rizzato, Angelica
Clerici, Michele
Volpe, Giulio
Menghini, Moreno
Grimaldi, Gabriela https://orcid.org/0000-0003-2435-7867
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 11 September 2024
First Online: 28 September 2024
Declarations
:
: Gabriel Grimaldi provided consulting and/or speaker services for Abbvie, Apellis, Bayer and Roche. Moreno Menghini provided consulting and/or speaker services for Abbvie, Apellis, Bayer, Novartis, Roche and he is consultant and holds equity of Endogena Inc. Michele Clerici provided consulting service for Bayer and Roche. Giuseppe Cancian, Arianna Paris, Lia Agliati, Angelica Rizzato and Giulio Volpe have nothing to disclose.
: The study protocol was reviewed and approved locally by the ethics committee of Canton Ticino (CE 4340), with approval number 2023-00653. Written informed consent was obtained from all patients. The research and data handling were conducted in compliance with the tenets of the Declaration of Helsinki and its amendments.
